Improving contact area between the peritoneum and intraperitoneal therapeutic solutions

Area of Science:

• Peritoneal Physiology
• Drug Delivery Systems
• Biomedical Engineering

Background:

• Current intraperitoneal therapies assume complete peritoneal contact with large fluid volumes.
• Limited contact area may reduce the efficacy of peritoneal dialysis and chemotherapy.
• Previous research suggests incomplete peritoneal fluid distribution.

Purpose of the Study:

• To quantify the actual peritoneal contact area achieved by intraperitoneal solutions.
• To investigate methods for increasing peritoneal contact area, including agitation and surfactants.
• To evaluate the dose-response relationship between surfactant concentration and contact area.

Main Methods:

• Developed a novel method to simultaneously measure peritoneal contact area and anatomic area in mice.
• Utilized radiolabeled proteins to track solution adherence to the peritoneum.
• Analyzed autoradiograms and corresponding histologic slides to calculate the contact area ratio.

Main Results:

• Under quiescent conditions, only 43% of the mouse peritoneum contacted the solution within 1 hour.
• Agitation increased contact area to 54% (P < 0.05).
• The surfactant dioctyl sodium sulfosuccinate (DSS) increased contact area to 107% (P < 0.001), with a dose-dependent effect.

Conclusions:

• A significant portion of the peritoneum remains uncovered by standard intraperitoneal solutions.
• Agitation and surfactants, particularly DSS, enhance peritoneal solution contact.
• Optimized surfactant concentrations can maximize contact area for improved intraperitoneal therapies.